PSYGF

Psyence Group Inc.

Psyence Taps Another Pharma Exec to Drive its Clinical Program

TORONTO, May 31, 2022 -- Psyence Group Inc. (CSE: PSYGย |ย OTCQB: PSYGF)ย (โ€œPsyenceโ€ or the โ€œCompanyโ€), a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being, is pleased to announce the appointment of Dr. Clive Ward-Able as the Medical Director of Psyence Group, effective immediately.... Read More...

Psyence Awarded ISO Certification through the British Standards Institute for its Natural Psilocybin Production Facility

TORONTO, Feb. 07, 2022 -- Psyence Group Inc. (CSE: PSYGย |ย OTCQB: PSYGF)ย (โ€œPsyenceโ€ or the โ€œCompanyโ€), a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being, is pleased to announce that its ISO22000 graded Psilocybin production facility has officially received International Organiza... Read More...

Psyence looks to expand capital market opportunities in the UK and Europe

TORONTO, Jan. 21, 2022 -- Psyence Group Inc. (CSE: PSYGย |ย OTCQB: PSYGF)ย (โ€œPsyenceโ€ or the โ€œCompanyโ€), a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being, announces that it is exploring capital market opportunities to access a broader pool of United Kingdom (โ€œUKโ€) and European in... Read More...

Psyence to Present at the H.C Wainwright 2nd Annual Psychedelics Conference December 6

TORONTO, Dec. 03, 2021 -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (โ€œPsyenceโ€ or the โ€œCompanyโ€), a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being, is pleased to announce that Psyence Chief Executive Officer, Neil Maresky, will be presenting at the virtual H.C. Wainwright ... Read More...

Psyence Group Announces Private Placement

TORONTO, Dec. 02, 2021 -- Psyence Group Inc. (CSE: PSYGย |ย OTCQB: PSYGF)ย (โ€œPsyenceโ€ or the โ€œCompanyโ€), a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being, announces that it is commencing a non-brokered private placement offering of up to CAD$2,000,000 of unsecured convertible pro... Read More...